Breaking Finance News

Zacks Investment Research downgraded Hill-Rom Holdings, Inc. (NYSE:HRC) to Hold in a report released today.

Boasting a price of $59.40, Hill-Rom Holdings, Inc. (NYSE:HRC) traded 0.57% lower on the day. The last stock close is up 13.85% from the two hundred day moving average, compared with the Standard & Poor’s 500 Index which has fallen -0.01% over the same period. The company has been tracking to a 50-day moving average of $58.05 and two hundred day moving average of $52.13. Trading volume was was down over the average, with 233,541 shares of HRC changing hands under the typical 551,084 shares.

Zacks Investment Research has downgraded Hill-Rom Holdings, Inc.(NYSE:HRC) to Hold in a statement released 9/20/2016.

On Friday April 8 2016, Goldman Sachs released a statement about Hill-Rom Holdings, Inc.(NYSE:HRC) raised the target price from $52.00 to $55.00 that suggested an upside of 0.05%.

Recent Performance Graph:

Hill-Rom Holdings, Inc. (NYSE:HRC)

Hill-Rom Holdings, Inc. has a 52 week low of $42.99 and a 52 week high of $60.48 with a P/E ratio of 61. The company’s total market value is presently $0.0.

More About Hill-Rom Holdings, Inc. (NYSE:HRC)

Hill-Rom Holdings, Inc. is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn. The North America segments sells and rents its support and near-patient technologies and services, as well as its clinical workflow solutions in the United States and Canada. The Surgical and Respiratory Care segment sells and rents its surgical and respiratory care products across the globe. Its International segment sells and rents similar products as the Company’s North America segment in regions outside of the United States and Canada. Its Welch Allyn segment sells medical diagnostic equipment and a portfolio of devices that assess, diagnose, and treat and manage a range of illnesses and diseases across the globe.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *